Valuation: Dr. Reddy's Laboratories Limited

Market Cap 1,002B 10.35B 9.25B 8.63B 7.84B 14.77B 14.88B 104B 40.52B 509B 38.87B 38.03B 1,638B P/E 2027 *
27.2x
P/E 2028 * 20.8x
Enterprise Value 970B 10.02B 8.96B 8.36B 7.59B 14.29B 14.4B 100B 39.23B 493B 37.63B 36.82B 1,585B EV / Sales 2027 *
2.76x
EV / Sales 2028 * 2.42x
Free-Float
69.69%
Yield 2027 *
0.63%
Yield 2028 * 0.7%
1 day-1.86%
1 week-4.53%
Current month-4.53%
1 month+3.06%
3 months-12.83%
6 months-1.37%
Current year-7.16%
1 week 1,166.75
Extreme 1166.75
1,222.65
1 month 1,131.05
Extreme 1131.05
1,252
Current year 1,080.05
Extreme 1080.05
1,414.4
1 year 1,080.05
Extreme 1080.05
1,414.4
3 years 1,025.9
Extreme 1025.9
1,420.2
5 years 731
Extreme 731
1,420.2
10 years 377.6
Extreme 377.6
1,420.2
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2019
Director of Finance/CFO - 01/08/2024
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 13/05/2014
Chairman 65 02/04/2013
Director/Board Member 65 25/10/2018
Date Insider Type Main position Quantity % Market Cap. Importance
1/4/26 Other

Global Head of Quality and PV

35,600 0.0043% -
18/12/25 Other

Chairman

85,738,125 10.2732%
18/12/25 Other

Director

12,717,090 1.5238%
Change 5-day change 1-year change 3-year change Capi.($)
-1.86%-4.53%-5.54%+8.84% 10.35B
-4.56%-0.74%+34.96%+99.63% 1,060B
-2.14%-2.09%+33.51%+59.74% 623B
-1.88%+2.54%+15.27%+78.76% 480B
-2.60%-3.04%+61.39%+33.44% 352B
-2.03%+1.06%+21.08%+40.60% 345B
-1.92%-0.29%+10.54%+33.58% 274B
-2.36%-1.16%-7.14%+9.54% 249B
-3.00%-1.45%+36.24%+47.82% 223B
-1.30%-1.74%+22.56%+93.09% 182B
Average -2.35%-0.71%+22.29%+50.50% 379.84B
Weighted average by Cap. -2.81%+0.03%+28.27%+64.66%

Financials

2027 *2028 *
Net sales 352B 3.64B 3.25B 3.03B 2.75B 5.19B 5.23B 36.44B 14.24B 179B 13.66B 13.36B 575B 393B 4.06B 3.63B 3.39B 3.08B 5.8B 5.84B 40.71B 15.91B 200B 15.26B 14.93B 643B
Net income 36.59B 378M 338M 315M 286M 539M 543M 3.79B 1.48B 18.61B 1.42B 1.39B 59.82B 48.56B 502M 449M 418M 380M 716M 721M 5.03B 1.96B 24.7B 1.88B 1.84B 79.39B
Net Debt -31.94B -330M -295M -275M -250M -471M -474M -3.31B -1.29B -16.24B -1.24B -1.21B -52.21B -51.42B -532M -475M -443M -403M -758M -764M -5.33B -2.08B -26.15B -2B -1.95B -84.07B
Projected Income Statement - Annual - Dr. Reddy's Laboratories Limited
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
08/10/26 INR 1,180.00 -1.86% 126,097
07/10/26 INR 1,202.40 -0.56% 69,824
06/10/26 INR 1,209.15 +0.10% 60,625
05/10/26 INR 1,208.00 +0.66% 199,793
01/10/26 INR 1,200.10 -2.90% 111,629
Trader
Investor
Global
Quality
ESG MSCI
BBB
Ratings Surperformance© - Dr. Reddy's Laboratories Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
1,202.40INR
Average target price
1,277.97INR
Spread / Average Target
+6.29%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Dr. Reddy's Laboratories Limited
  1. Stock Market
  2. Stocks
  3. DRREDDY Stock